NovaBay Pharmaceuticals Statistics
Total Valuation
NBY has a market cap or net worth of $137.35 million. The enterprise value is $136.01 million.
Important Dates
The last earnings date was Friday, November 7, 2025, after market close.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NBY has 126.01 million shares outstanding. The number of shares has increased by 831.36% in one year.
| Current Share Class | 126.01M |
| Shares Outstanding | 126.01M |
| Shares Change (YoY) | +831.36% |
| Shares Change (QoQ) | +1.00% |
| Owned by Insiders (%) | 45.08% |
| Owned by Institutions (%) | 0.99% |
| Float | 12.39M |
Valuation Ratios
The trailing PE ratio is 42.35.
| PE Ratio | 42.35 |
| Forward PE | n/a |
| PS Ratio | 0.74 |
| Forward PS | 9.97 |
| PB Ratio | 84.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 46.51 |
| P/OCF Ratio | 46.45 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 41.94 |
| EV / Sales | 13.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 46.06 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.59.
| Current Ratio | 2.00 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.33 |
| Interest Coverage | -155.27 |
Financial Efficiency
Return on equity (ROE) is -516.26% and return on invested capital (ROIC) is -129.71%.
| Return on Equity (ROE) | -516.26% |
| Return on Assets (ROA) | -86.98% |
| Return on Invested Capital (ROIC) | -129.71% |
| Return on Capital Employed (ROCE) | -251.30% |
| Revenue Per Employee | $735,857 |
| Profits Per Employee | $231,643 |
| Employee Count | 14 |
| Asset Turnover | 2.80 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +83.32% in the last 52 weeks. The beta is 0.48, so NBY's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +83.32% |
| 50-Day Moving Average | 1.28 |
| 200-Day Moving Average | 0.93 |
| Relative Strength Index (RSI) | 49.31 |
| Average Volume (20 Days) | 128,803 |
Short Selling Information
The latest short interest is 73,685, so 0.06% of the outstanding shares have been sold short.
| Short Interest | 73,685 |
| Short Previous Month | 514,318 |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.59% |
| Short Ratio (days to cover) | 0.24 |
Income Statement
In the last 12 months, NBY had revenue of $10.30 million and earned $3.24 million in profits. Earnings per share was $0.47.
| Revenue | 10.30M |
| Gross Profit | 6.52M |
| Operating Income | -5.12M |
| Pretax Income | -6.99M |
| Net Income | 3.24M |
| EBITDA | -5.10M |
| EBIT | -5.12M |
| Earnings Per Share (EPS) | $0.47 |
Full Income StatementBalance Sheet
The company has $2.31 million in cash and $970,000 in debt, giving a net cash position of $1.34 million or $0.01 per share.
| Cash & Cash Equivalents | 2.31M |
| Total Debt | 970,000 |
| Net Cash | 1.34M |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 1.63M |
| Book Value Per Share | -0.45 |
| Working Capital | 1.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.96 million and capital expenditures -$4,000, giving a free cash flow of $2.95 million.
| Operating Cash Flow | 2.96M |
| Capital Expenditures | -4,000 |
| Free Cash Flow | 2.95M |
| FCF Per Share | $0.02 |
Full Cash Flow StatementMargins
Gross margin is 63.32%, with operating and profit margins of -49.74% and 31.48%.
| Gross Margin | 63.32% |
| Operating Margin | -49.74% |
| Pretax Margin | -67.80% |
| Profit Margin | 31.48% |
| EBITDA Margin | -49.53% |
| EBIT Margin | -49.74% |
| FCF Margin | 28.66% |
Dividends & Yields
NBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -831.36% |
| Shareholder Yield | -831.36% |
| Earnings Yield | 2.36% |
| FCF Yield | 2.15% |
Dividend DetailsAnalyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 31, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | May 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
NBY has an Altman Z-Score of -73.79 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -73.79 |
| Piotroski F-Score | 5 |
